Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molsidomine add-on therapy for atherosclerosis progression after non-ST-elevation acute coronary syndrome
2005-004727-18Phase 2Completed
- Sponsor
- Therabel
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute coronary syndrome (ACS), atherosclerosis and coronary arteriosclerosis comparing CORUNO add-on with Placebo add-on (2 arms). Primary endpoints: Primary composite endpoint and Plaque burden assessment. Started Aug 2006; status: completed.
02
Drugs
molsidomine
03
Conditions
acute coronary syndrome (ACS)atherosclerosiscoronary arteriosclerosis
Beyond the preview
Go deeper on 2005-004727-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004727-18.